Patients at Home Benefit From Inotropic Infusion

The study found that 64.5% of terminal heart failure patients receiving care through an inotropic infusion program were able to spend their final days at home or in hospice rather than in a hospital or other medical facility. That rate compared with 35.9% in an age- and sex-adjusted national sample.

To read the rest of this article
CLICK HERE